Fourteen-days Evolution of COVID-19 Symptoms During the Third Wave in Non-vaccinated Subjects and Effects of Hesperidin Therapy: A randomized, double-blinded, placebo-controlled study

Jocelyn Dupuis, Pierre Laurin, Jean-Claude Tardif, Leslie Hausermann, Camille Rosa, Marie-Claude Guertin, Karen Thibaudeau, Lyne Gagnon, Frank Cesari, Martin Robitaille, John E. Moran
doi: https://doi.org/10.1101/2021.10.04.21264483

Article usage

Article usage: October 2021 to January 2025

AbstractFullPdf
Oct 2021118838231
Nov 202141611663
Dec 20216624966
Jan 202242517951
Feb 202218011725
Mar 202221412512
Apr 20221308430
May 202212510820
Jun 2022799022
Jul 2022867311
Aug 2022853722
Sep 2022841717
Oct 202286222
Nov 202278316
Dec 2022521111
Jan 2023461015
Feb 202341412
Mar 202336318
Apr 202336117
May 202316315
Jun 20231595
Jul 20232039
Aug 2023271114
Sep 202320617
Oct 20231849
Nov 2023371313
Dec 20232304
Jan 202418313
Feb 202411712
Mar 202420513
Apr 202425919
May 20241129
Jun 202438810
Jul 202423313
Aug 2024311014
Sep 202438816
Oct 20241637
Nov 202422014
Dec 202421217
Jan 2025917
Back to top
Posted October 07, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Fourteen-days Evolution of COVID-19 Symptoms During the Third Wave in Non-vaccinated Subjects and Effects of Hesperidin Therapy: A randomized, double-blinded, placebo-controlled study
Jocelyn Dupuis, Pierre Laurin, Jean-Claude Tardif, Leslie Hausermann, Camille Rosa, Marie-Claude Guertin, Karen Thibaudeau, Lyne Gagnon, Frank Cesari, Martin Robitaille, John E. Moran
medRxiv 2021.10.04.21264483; doi: https://doi.org/10.1101/2021.10.04.21264483
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area